Search

You searched for "correction"

2996 results found

International eyecare charity Orbis and Tom Davies Eyewear take on Africa's biggest road race

1 December 2025 | charity, international
Blindness prevention charity Orbis and Tom Davies Eyewear take on Africa’s biggest road race and raise over 80,000. The team braved high altitude and heat to raise vital funds for the charity’s sight-saving work across Ethiopia. On 23rd November, eleven...

Paediatric ophthalmology training in Africa through the Juba-Bournemouth VISION 2020 LINK

1 December 2018 | | EYE - Paediatrics, EYE - Strabismus, EYE - General
One of the aims of the College of Ophthalmology of Eastern, Central and Southern Africa (COECSA) is to provide specialist ophthalmic training for practising ophthalmologists from its 11 member countries. A number of initiatives are enabling more ophthalmologists to undertake...

In conversation with Robert Henderson

14 November 2024 | EYE - Imaging, EYE - Paediatrics, EYE - Vitreo-Retinal
Revolutionary eye treatments offer hope for children facing blindness from CLN2 batten disease. Robert Henderson discusses this, and his use of Heidelberg Engineering’s Spectralis device to better combat it. Pioneering research from Great Ormond Street Hospital (GOSH) and the University...

The meaning of life

1 December 2021 | | EYE - Vitreo-Retinal, EYE - General
Supercomputer: “The answer to the great question of Life, the Universe and Everything is…”Programmer: “Yes…?”Supercomputer: “42. It was a tough assignment”.Programmer: “42? Is that all you have got to show for seven and a half million years work?” In this...

An anterior segment lump: a diagnostic and treatment challenge

2 February 2024 | | EYE - Oncology, EYE - Pathology
Case presentation A 50-year-old female presented to eye casualty with a lump on the left medial lower eyelid with associated redness and occasional bleeding. The lump was present for a few months with recent enlargement (Figure 1). Her past medical...

COVID-19: Pete’s Bogus Journey

6 April 2021 | | EYE - General
The author shares his personal experience of contracting coronavirus. I managed to body swerve COVID-19 for nine months. The Pfizer vaccine was being rolled out in my trust. I had my first inoculation booked in three weeks. I had survived...

Dr Glaucomflecken: Stayin’ Alive

13 October 2022 | | EYE - General
Peter Cackett spoke to ophthalmologist and social media sensation Dr Glaucomflecken about his early days in comedy, the role satire can play in impacting medical governance, and where he might take his brand of medical comedy next. It was towards...

Idiopathic intracranial hypertension (IIH)

3 June 2021 | | EYE - Neuro-ophthalmology, EYE - General
IIH is a medical condition where the intracranial pressure (ICP) is raised without an obvious cause. The cerebrospinal fluid (CSF) is produced in by the choroid plexus in the lateral ventricles and the roof of the third and fourth ventricles,...

The Sickle Cell Retinopathy Network is leading global change in screening and management

2 October 2025 | | EYE - Vitreo-Retinal
Sickle cell disease or disorder (SCD) is one of the most neglected health conditions in the world. A strong hypothesis is that this is because SCD affects people of African, Caribbean and other Global Majority communities and has received disproportionately...

In conversation with Captain Gary Dyson

25 July 2022 | | EYE - General
Captain Gary Dyson, Chief Pilot of the Orbis Flying Eye Hospital, spoke to Chris Henson about his 22-year stint flying the plane, its role at the cutting edge of aviation and medical technology, and how Orbis plan to continue to...

Semaglutide and vision loss: A new concern for NAION risk?

4 December 2025 | | EYE - Neuro-ophthalmology
This article has been verified for CPD. Click the button below to answer a few short questions and download a form to be included in your CPD folder. Glucagon-like peptide-1 receptor agonists (GLP-1 RAs) have emerged as transformative agents in...

PACK-crosslinking for infectious keratitis

1 October 2015 | | EYE - Cornea
Corneal cross-linking with riboflavin and UV-A light (CXL) is a technology that has been initially developed to treat corneal ectatic disorders [1]. Its effect in stabilising diseases such as keratoconus was reported in numerous trials with excellent long-term outcomes and...